Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Cancer Lett
    August 2017
  1. OTTAIANO A, Nasti G, Cassata A, De Stefano A, et al
    FOLFOXIRI in metastatic colorectal cancer: a criticism from its native land.
    Cancer Lett. 2017 Aug 24. pii: S0304-3835(17)30512.
    >> Share

  2. OBERTHUR R, Seemann H, Gehrig J, Rave-Frank M, et al
    Simultaneous inhibition of IGF1R and EGFR enhances the efficacy of standard treatment for colorectal cancer by the impairment of DNA repair and the induction of cell death.
    Cancer Lett. 2017 Aug 18. pii: S0304-3835(17)30486.
    >> Share

  3. TAGHAVI S, Ramezani M, Alibolandi M, Abnous K, et al
    Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Cancer Lett. 2017;400:1-8.
    >> Share

    June 2017
  4. LOW YS, Blocker C, McPherson JR, Tang SA, et al
    A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.
    Cancer Lett. 2017;403:13-20.
    >> Share

  5. SUI H, Zhao J, Zhou L, Wen H, et al
    Tanshinone IIAinhibits beta-catenin/VEGF-mediated angiogenesis by targeting TGF-beta1 in normoxic and HIF-1alphainhypoxicmicroenvironments in human colorectal cancer.
    Cancer Lett. 2017 Jun 7. pii: S0304-3835(17)30347.
    >> Share

  6. DONG X, Liao W, Zhang L, Tu X, et al
    RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
    >> Share

  7. NAGARAJU GP, Wu C, Merchant N, Chen Z, et al
    Epigenetic effects of inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer.
    Cancer Lett. 2017 Jun 3. pii: S0304-3835(17)30357.
    >> Share

    May 2017
  8. NAKAMURA Y, Hattori N, Iida N, Yamashita S, et al
    Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway.
    Cancer Lett. 2017 May 31. pii: S0304-3835(17)30353.
    >> Share

  9. LIN F, Zhang P, Zuo Z, Wang F, et al
    Thioredoxin-1 Promotes Colorectal Cancer Invasion and Metastasis through Crosstalk with S100P.
    Cancer Lett. 2017 May 5. pii: S0304-3835(17)30308.
    >> Share

  10. XIANG J, Sun H, Su L, Liu L, et al
    Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1alpha.
    Cancer Lett. 2017 May 4. pii: S0304-3835(17)30309.
    >> Share

    April 2017
  11. DU C, Huang D, Peng Y, Yao Y, et al
    5-Fluorouracil Targets Histone Acetyltransferases p300/CBP in the Treatment of Colorectal Cancer.
    Cancer Lett. 2017 Apr 29. pii: S0304-3835(17)30294.
    >> Share

  12. OU C, Sun Z, Li X, Li X, et al
    MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer.
    Cancer Lett. 2017 Apr 19. pii: S0304-3835(17)30241.
    >> Share

    March 2017
  13. KOUSTAS E, Karamouzis MV, Mihailidou C, Schizas D, et al
    Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer.
    Cancer Lett. 2017 Mar 18. pii: S0304-3835(17)30197.
    >> Share

  14. WANG YJ, Zhang YK, Zhang GN, Al Rihani SB, et al
    Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.
    Cancer Lett. 2017 Mar 13. pii: S0304-3835(17)30175.
    >> Share

  15. WOO IS, Jung YH
    Metronomic chemotherapy in metastatic colorectal cancer.
    Cancer Lett. 2017 Mar 5. pii: S0304-3835(17)30151.
    >> Share

    February 2017
  16. BADAWI A, Hehlgans S, Pfeilschifter J, Rodel F, et al
    Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
    Cancer Lett. 2017 Feb 17. pii: S0304-3835(17)30110.
    >> Share

  17. PAN Q, Meng L, Ye J, Wei X, et al
    Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Cancer Lett. 2017 Feb 2. pii: S0304-3835(17)30081.
    >> Share

    January 2017
  18. EDER S, Arndt A, Lamkowski A, Daskalaki W, et al
    Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
    Cancer Lett. 2017;385:160-167.
    >> Share

  19. LIU R, Tang J, Ding C, Liang W, et al
    The depletion of ATM inhibits colon cancer proliferation and migration via B56gamma2-mediated Chk1/p53/CD44 cascades.
    Cancer Lett. 2017 Jan 13. pii: S0304-3835(17)30024.
    >> Share

  20. XIE R, Wang J, Tang W, Li Y, et al
    Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer.
    Cancer Lett. 2017 Jan 12. pii: S0304-3835(17)30015.
    >> Share

    December 2016
  21. LI Y, Oliver PG, Lu W, Pathak V, et al
    SRI36160 is a specific inhibitor of Wnt/beta-catenin signaling in human pancreatic and colorectal cancer cells.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30800.
    >> Share

  22. CERDA MB, Lloyd R, Batalla M, Giannoni F, et al
    Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin.
    Cancer Lett. 2016;388:312-319.
    >> Share

  23. HUANG GL, Zhang W, Ren HY, Zhou P, et al
    Oncogenic retinoic acid receptor alpha promotes human colorectal cancer growth through simultaneously regulating p21 transcription and GSK3beta/beta-catenin signaling.
    Cancer Lett. 2016 Dec 5. pii: S0304-3835(16)30743.
    >> Share

  24. WANG FF, Zhang XJ, Yan YR, Zhu XH, et al
    FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal cancer.
    Cancer Lett. 2016 Dec 1. pii: S0304-3835(16)30732.
    >> Share

    November 2016
  25. DONG R, Gong Y, Meng W, Yuan M, et al
    The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer.
    Cancer Lett. 2016 Nov 30. pii: S0304-3835(16)30717.
    >> Share

  26. YAN C, Luo L, Guo CY, Goto S, et al
    Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells.
    Cancer Lett. 2016 Nov 30. pii: S0304-3835(16)30706.
    >> Share

  27. ZHANG WJ, Li Y, Wei MN, Chen Y, et al
    Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer.
    Cancer Lett. 2016 Nov 15. pii: S0304-3835(16)30697.
    >> Share

  28. ABU LILA AS, Moriyoshi N, Fukushima M, Huang CL, et al
    Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model.
    Cancer Lett. 2016 Nov 9. pii: S0304-3835(16)30683.
    >> Share

  29. JO YK, Roh SA, Lee H, Park NY, et al
    Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Cancer Lett. 2016;385:21-27.
    >> Share

  30. ZHOU P, Xiao N, Wang J, Wang Z, et al
    SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis.
    Cancer Lett. 2016 Nov 4. pii: S0304-3835(16)30672.
    >> Share

  31. PLATET N, Hinkel I, Richert L, Murdamoothoo D, et al
    The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton.
    Cancer Lett. 2016 Nov 2. pii: S0304-3835(16)30671.
    >> Share

    October 2016
  32. DE MIGUEL D, Gallego Lleyda A, Ayuso JM, Pejenaute-Ochoa D, et al
    High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.
    Cancer Lett. 2016 Oct 8. pii: S0304-3835(16)30612.
    >> Share

  33. DU J, Wang Y, Chen D, Ji G, et al
    BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-kappaB.
    Cancer Lett. 2016 Oct 6. pii: S0304-3835(16)30609.
    >> Share

  34. WEN C, Chen J, Zhang D, Wang H, et al
    Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Cancer Lett. 2016 Oct 3. pii: S0304-3835(16)30549.
    >> Share

    September 2016
  35. MOLCK C, Ryall J, Failla LM, Coates JL, et al
    The A2b adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanism.
    Cancer Lett. 2016 Sep 28. pii: S0304-3835(16)30560.
    >> Share

    August 2016
  36. HU S, Dai H, Li T, Tang Y, et al
    Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.
    Cancer Lett. 2016 Aug 26. pii: S0304-3835(16)30497.
    >> Share

  37. WANG R, Kang Y, Lohr CV, Fischer KA, et al
    Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer.
    Cancer Lett. 2016;381:341-348.
    >> Share

  38. ZHANG X, Chen Y, Hao L, Hou A, et al
    Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine.
    Cancer Lett. 2016 Aug 8. pii: S0304-3835(16)30461.
    >> Share

    July 2016
  39. KONG J, Sun W, Li C, Wan L, et al
    Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
    Cancer Lett. 2016;380:476-484.
    >> Share

  40. OU B, Zhao J, Guan S, Wangpu X, et al
    Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
    Cancer Lett. 2016 Jul 13. pii: S0304-3835(16)30398.
    >> Share

    June 2016
  41. TANABE A, Tanikawa K, Tsunetomi M, Takai K, et al
    RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1alpha mRNA is translated.
    Cancer Lett. 2016;376:34-42.
    >> Share

  42. YOSHII Y, Furukawa T, Matsumoto H, Yoshimoto M, et al
    (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
    Cancer Lett. 2016;376:74-82.
    >> Share

  43. LU YX, Ju HQ, Wang F, Chen LZ, et al
    Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Cancer Lett. 2016 Jun 17. pii: S0304-3835(16)30374.
    >> Share

    May 2016
  44. KUO CT, Lee WS
    Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines.
    Cancer Lett. 2016;378:104-110.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016